Companies Dominating the Folate Landscape
- ITM Isotope Technologies Munich SE (ITM)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ImmunoGen Inc.
- Medicamen Biotech Ltd.
- Koninklijke DSM N.V
- Superior Supplement Manufacturing
- Gnosis
- Seidler Chemical Co, Inc.
- Nutritional Supplement Manufacturers, Inc.
- AIE Pharmaceuticals, Inc.
- Gemini Pharmaceuticals
The folate market is predicted to be greatly influenced by the initiatives of the key players. These key players are significantly investing in R&D activities and collaborating with a number of companies to make their development reach the world. Some of the major players include:
Browse Key Market Insights with Data Illustration:
In the News
- ITM Isotope Technologies Munich SE (ITM), disclosed that it has entered into a license agreement with Merck KGaA's life science business in Darmstadt, Germany, to secure a worldwide exclusive license for the clinical research and marketing of radiolabeled folate derivatives for therapeutic and diagnostic applications against folate-receptor-positive malignant tumors.
- ImmunoGen Inc. garnered accelerated approval from the US Food and Drug Administration (FDA) for ELAHERE (mirvetuximab soravtansine-gynx), which is used to treat adult patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have undergone one to three prior systemic treatments.
